Casdin Eli (CIK 0001534264)

Latest company ownership

Shares held
91,534,918
Last filed at
Dec 4, 2025
Confidence Score
97.4
2025Q4
Confidence Score History
2023Q2 2025Q4
MXCT - MAXCYTE, INC.
Role: 10% Owner
Shares held
10,000,000
Last filed at
Oct 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
5,957,165
Last filed at
Oct 17, 2025
Confidence Score
12.7
2025Q4
Confidence Score History
2019Q4 2025Q4
Shares held
1,354,111
Last filed at
Nov 25, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
464,285
Last filed at
Jul 22, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
GBIO - Generation Bio Co.
Role: 10% Owner
Shares held
257,883
Last filed at
Jun 18, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ABSI - Absci Corp
Role: Director
Shares held
28,700
Last filed at
Jun 10, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
19,872
Last filed at
Jun 10, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
12,836
Last filed at
May 12, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 2, 2025 Dec 4, 2025 STANDARD BIOTOOLS INC. Director Buy 67.5 +350,000 0.47% ✗ $502.6K
Nov 24, 2025 Nov 26, 2025 STANDARD BIOTOOLS INC. Director Buy 100.0 +7,700,000 11.50% ✗ $10.1M
Nov 18, 2025 Nov 20, 2025 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,075,000 1.63% ✗ $1.4M
Nov 13, 2025 Nov 17, 2025 STANDARD BIOTOOLS INC. Director Buy 87.5 +925,000 1.37% ✗ $1.1M
Nov 7, 2025 Nov 12, 2025 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,175,000 1.84% ✗ $1.4M
Oct 15, 2025 Oct 17, 2025 BIOLIFE SOLUTIONS INC 10% Owner Sell 15.0 -750,000 -11.18% ✗ $21.4M
Sep 9, 2025 Sep 11, 2025 STANDARD BIOTOOLS INC. Director Buy 60.0 +100,000 0.16% ✗ $128.9K
Sep 3, 2025 Sep 5, 2025 STANDARD BIOTOOLS INC. Director Buy 75.0 +500,000 0.79% ✗ $635.8K
Aug 22, 2025 Aug 26, 2025 STANDARD BIOTOOLS INC. Director Buy 75.0 +525,000 0.84% ✗ $658.8K
Aug 22, 2025 Aug 22, 2025 GeneDx Holdings Corp. Director Sell 15.0 -500,000 -14.17% ✗ $60.5M
Aug 15, 2025 Aug 21, 2025 BIOLIFE SOLUTIONS INC 10% Owner Sell 15.0 -500,000 -6.94% ✗ $12.2M
Aug 13, 2025 Aug 15, 2025 STANDARD BIOTOOLS INC. Director Buy 75.0 +358,220 0.58% ✗ $443K
Aug 11, 2025 Aug 13, 2025 BIOLIFE SOLUTIONS INC 10% Owner Sell 15.0 -500,000 -6.49% ✗ $11.3M
Jun 10, 2025 Jun 12, 2025 BIOLIFE SOLUTIONS INC 10% Owner Sell 15.0 -1,000,000 -11.48% ✗ $23.8M
Feb 28, 2025 Mar 4, 2025 STANDARD BIOTOOLS INC. Director Buy 93.8 +4,879,174 4.20% ✗ $5.1M
Aug 27, 2024 Aug 29, 2024 STANDARD BIOTOOLS INC. Director Buy 67.5 +250,000 0.44% ✗ $546.8K
Aug 22, 2024 Aug 26, 2024 STANDARD BIOTOOLS INC. Director Buy 77.5 +750,000 0.69% ✗ $1.5M
Aug 19, 2024 Aug 21, 2024 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,250,000 2.29% ✗ $2.4M
Aug 14, 2024 Aug 16, 2024 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,200,000 2.25% ✗ $1.9M
Aug 9, 2024 Aug 13, 2024 STANDARD BIOTOOLS INC. Director Buy 92.5 +1,575,408 3.04% ✗ $2.6M
Aug 7, 2024 Aug 9, 2024 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,069,562 1.08% ✗ $1.7M
Aug 2, 2024 Aug 6, 2024 STANDARD BIOTOOLS INC. Director Buy 87.5 +1,200,000 1.89% ✗ $1.9M
Aug 1, 2024 Aug 5, 2024 GeneDx Holdings Corp. Director Buy 100.0 +413,655 12.00% ✗ $13.3M
Jun 3, 2024 Jun 5, 2024 GeneDx Holdings Corp. Director Buy 92.5 +130,000 3.49% ✗ $2.8M
May 29, 2024 May 31, 2024 GeneDx Holdings Corp. Director Buy 85.0 +40,000 1.08% ✗ $842.6K
May 23, 2024 May 28, 2024 STANDARD BIOTOOLS INC. Director Buy 67.5 +100,000 0.22% ✗ $260K
May 23, 2024 May 28, 2024 GeneDx Holdings Corp. Director Buy 92.5 +170,000 4.83% ✗ $3.4M
May 20, 2024 May 22, 2024 STANDARD BIOTOOLS INC. Director Buy 87.5 +600,000 1.32% ✗ $1.5M
May 15, 2024 May 17, 2024 STANDARD BIOTOOLS INC. Director Buy 92.5 +1,352,072 3.06% ✗ $3.5M
May 13, 2024 May 15, 2024 GeneDx Holdings Corp. Director Buy 87.5 +50,000 1.44% ✗ $1.2M
Mar 4, 2024 Mar 6, 2024 GeneDx Holdings Corp. Director Buy 85.0 +40,900 1.19% ✗ $357.7K
Mar 4, 2024 Mar 6, 2024 STANDARD BIOTOOLS INC. Director Buy 85.0 +251,403 1.11% ✗ $646.2K
Oct 19, 2023 Oct 23, 2023 BIOLIFE SOLUTIONS INC 10% Owner Buy 100.0 +927,165 11.92% ✗ $10.4M
Aug 9, 2023 Aug 11, 2023 BIOLIFE SOLUTIONS INC 10% Owner Buy 75.0 +58,465 0.76% ✗ $771.7K
May 19, 2023 May 23, 2023 BIOLIFE SOLUTIONS INC 10% Owner Buy 77.5 +74,973 0.98% ✗ $1.7M
May 17, 2023 May 19, 2023 STANDARD BIOTOOLS INC. Director Buy 100.0 +1,200,000 2565.97% ✗ $2.6M
May 16, 2023 May 18, 2023 BIOLIFE SOLUTIONS INC 10% Owner Buy 77.5 +75,027 0.99% ✗ $1.6M
Jan 31, 2023 Feb 2, 2023 GeneDx Holdings Corp. Director Buy 100.0 +85,714,285 312.32% ✗ $30M
Nov 17, 2022 Nov 25, 2022 Tenaya Therapeutics, Inc. Director Buy 100.0 +2,492,042 69.48% ✗ $6.5M
Oct 3, 2022 Oct 5, 2022 MAXCYTE, INC. 10% Owner Sell 17.5 -735,786 -6.85% ✗ $4.5M
Jul 1, 2022 Jul 6, 2022 MAXCYTE, INC. 10% Owner Sell 15.0 -3,235,548 -23.16% ✗ $13.9M
Apr 29, 2022 May 3, 2022 GeneDx Holdings Corp. Director Buy 100.0 +11,437,500 71.51% ✗ $45.8M
Aug 3, 2021 Aug 4, 2021 Tenaya Therapeutics, Inc. Director Buy 100.0 +850,000 35.79% ✗ $12.8M
Jul 30, 2021 Aug 3, 2021 MAXCYTE, INC. 10% Owner Buy 100.0 +1,800,000 14.79% ✗ $23.4M
Jul 26, 2021 Jul 28, 2021 Absci Corp Director Buy 100.0 +1,562,500 30.15% ✗ $25M
Jun 22, 2021 Jun 22, 2021 Century Therapeutics, Inc. Director Buy 100.0 +750,000 30.53% ✗ $15M
Nov 24, 2020 Nov 27, 2020 BIOLIFE SOLUTIONS INC 10% Owner Buy 100.0 +1,600,000 27.40% ✗ $36M
Jul 1, 2020 Jul 2, 2020 BIOLIFE SOLUTIONS INC 10% Owner Buy 100.0 +990,583 20.43% ✗ $14.4M
Jun 16, 2020 Jun 18, 2020 Generation Bio Co. 10% Owner Buy 100.0 +650,000 67.62% ✗ $12.4M
May 22, 2020 May 26, 2020 BIOLIFE SOLUTIONS INC 10% Owner Buy 100.0 +476,191 10.89% ✗ $5M
May 14, 2020 May 18, 2020 BIOLIFE SOLUTIONS INC 10% Owner Buy 100.0 +1,904,762 77.16% ✗ $20M
Nov 19, 2019 Nov 21, 2019 BIOLIFE SOLUTIONS INC 10% Owner Buy 85.0 +40,000 1.65% ✗ $616.5K
Jul 22, 2019 Jul 22, 2019 Fulcrum Therapeutics, Inc. 10% Owner Buy 100.0 +140,000 30.15% ✗ $2.2M